AstraZeneca | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Sunday
February 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SUNDAY, FEBRUARY 05, 2023

AstraZeneca

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, US, Apr 8, 2019. (Photo: Reuters/Brendan McDermid)
Coronavirus chronicle

AstraZeneca's Covid vaccine suffers a setback in nasal spray trial

A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
Covid-19 in Bangladesh

AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match

Photo: Collected
Coronavirus chronicle

AstraZeneca Covid drug neutralises Omicron sub-variants in study

A healthcare professional prepares a dose of AstraZeneca (Covid-19) vaccine at the Narok County Referral Hospital, in Narok, Kenya, December 1, 2021. Photo: Reuters
Coronavirus chronicle

Short AstraZeneca shelf life complicates Covid vaccine rollout to world's poorest

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

New data finds AstraZeneca booster generates higher antibodies against Omicron

Some samples of expired AstraZeneca coronavirus disease (Covid-19) vaccines are seen at the Gosa dump site in Abuja, Nigeria, December 22, 2021. Photo :Reuters
Africa

Nigeria destroys 1 mln donated AstraZeneca vaccines with short shelf life

Vials labelled "Astra Zeneca Covid-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. Photo :Reuters
Covid-19 in Bangladesh

Another 7 lakh Covid-19 vaccines arrive in Bangladesh from Japan

A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters
Coronavirus chronicle

AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

Photo: Collected
Coronavirus chronicle

Bangladesh receives more AstraZeneca vaccines from France

Photo collected
Covid-19 in Bangladesh

Japan to provide more AstraZeneca vaccines to Bangladesh 21 Dec

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations

The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US, March 22, 2021.  Photo: Reuters
Coronavirus chronicle

AstraZeneca to supply Covid-19 antibody cocktail to Singapore

A health worker shows a vial of the AstraZeneca COVID-19 vaccine against the coronavirus disease (COVID-19) as Thailand start a mass inoculation at a gymnasium inside the Thammasat University in Pathum Thani, Thailand June 7, 2021. REUTERS/Athit Perawongmetha/File Photo
Coronavirus chronicle

US authorizes AstraZeneca antibody for cases reacting badly to vaccine

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net